Skip to main content

Advertisement

SpringerLink
Log in

Progressive multifocal leukoencephalopathy after interferon beta-1a monotherapy

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48

    Article  CAS  PubMed  Google Scholar 

  2. Happe S, Husstedt IW (2000) Successful treatment of acute encephalomyelitis associated with common variable immunodeficiency syndrome (CVID): case report and review of the literature. J Neurol 247:562–565

    Article  CAS  PubMed  Google Scholar 

  3. Narula S, LaRosa DF, Kamoun M, Dalmau J, Levinson AI (2007) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution. Ann Allergy Asthma Immunol 98:483–489

    Article  PubMed  Google Scholar 

  4. Park MA, Li JT, Hagan JB, Maddox DE, Abraham RS (2008) Common variable immunodeficiency: a new look at an old disease. Lancet 372:489–502

    Article  PubMed  Google Scholar 

  5. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O’Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302

    Article  PubMed Central  PubMed  Google Scholar 

  6. Rieckmann P, Heidenreich F, Sailer M, Zettl UK, Zessack N, Hartung HP, Gold R (2012) Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis. Ther Adv Neurol Disord 5:3–12

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Rudge P, Webster AD, Revesz T, Warner T, Espanol T, Cunningham-Rundles C, Hyman N (1996) Encephalomyelitis in primary hypogammaglobulinemia. Brain 119(Pt 1):1–15

    Article  PubMed  Google Scholar 

  8. Scotton PG, Vaglia A, Carniato A, Marchiori GC (1998) Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency. Clin Infect Dis 26:215–216

    Article  CAS  PubMed  Google Scholar 

  9. Snyder MD, Storch GA, Clifford DB (2005) Atypical PML leading to a diagnosis of common variable immunodeficiency. Neurology 64:1661

    Article  PubMed  Google Scholar 

  10. Wattjes MP, Richert ND, Killestein J, de Vos M, Sanchez E, Snaebjornsson P, Cadavid D, Barkhof F (2013) The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Mult Scler 19:1826–1840

    Article  CAS  PubMed  Google Scholar 

  11. Wenning W, Haghikia A, Laubenberger J, Clifford DB, Behrens PF, Chan A, Gold R (2009) Treatment of progressive multifocal leukoencephalopathy associated with natalizumab. N Engl J Med 361:1075–1080

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

HCL has received personal compensations and/or grant support from Baxter, Celgene, CSL Behring, Fresenius, Grifols, and Novartis. MS has received personal and/or institutional compensations from Almirall, Baxter, Bayer HealthCare, Boehringer Ingelheim, Biogen Idec, CSL Behring, Grifols, Merck Serono, Novartis, Sanofi-Genzyme, and Teva.

Ethical standard

This letter was written in accordance with the ethical standards laid down in the Declaration of Helsinki and its later amendments.

Author information

Authors and Affiliations

  1. Department of Neurology, University Hospital of Cologne, Kerpener Straße 62, 50937, Cologne, Germany

    Helmar C. Lehmann, Gereon R. Fink & Michael Schroeter

  2. Neurology Practice, Friedrich-Ebert-Platz 2B, 53773, Hennef, Germany

    Klaus Krüger

  3. Institute of Neuroscience and Medicine (INM-3), Research Center Jülich, Jülich, Germany

    Gereon R. Fink

Authors
  1. Helmar C. Lehmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Klaus Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gereon R. Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael Schroeter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helmar C. Lehmann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lehmann, H.C., Krüger, K., Fink, G.R. et al. Progressive multifocal leukoencephalopathy after interferon beta-1a monotherapy. J Neurol 262, 771–773 (2015). https://doi.org/10.1007/s00415-014-7620-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-014-7620-4

Keywords

Search

Navigation